CCL2 and colon adenoma: Intestinal ERβ, activated by TNFα, reduces colon adenomas by inhibiting TNFα/NFκB signaling. ERβ represses NFκB, upregulates inhibitor ATF3, and decreases CCL2 and CCL4 secretion, reducing pro-inflammatory macrophage recruitment.